SBI Securities’s Maravai LifeSciences MRVI Stock Holding History

SBI Securities’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.38K	Hold	311	–	–	﹤0.01%	2527
2026 Q2	$1.94K	Hold	311	–	–	﹤0.01%	2566
2026 Q1	$880	Hold	311	–	–	﹤0.01%	2702
2025 Q4	$1.01K	Sell	311 -103	-25%	-$347	﹤0.01%	2642
2025 Q3	$1.19K	Hold	414	–	–	﹤0.01%	2623
2025 Q2	$998	Buy	414 +90	+28%	+$189	﹤0.01%	2684
2025 Q1	$716	Sell	324 -85	-21%	-$336	﹤0.01%	2734
2024 Q4	$2.23K	Buy	+409	New	+$2.63K	﹤0.01%	2266

Other funds holding MRVI

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

SBI Securities's MRVI Position: Q3 2026 in Review

SBI Securities held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 311 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

SBI Securities first reported a position in MRVI in Q4 2024 and has held it in 8 quarters since. 14 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

SBI Securities held 311 shares of Maravai LifeSciences worth $2.38K as of Q3 2026.
SBI Securities left its Maravai LifeSciences share count unchanged in Q3 2026.
Maravai LifeSciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2527 holding.
SBI Securities first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 8 quarters since.
14 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.